Viral Quantification - Adeno-Associated Virus Vector Genome Titer Assay
By Martin Lock, Director, Process Development, Gene Therapy Program — University of Pennsylvania
![Gene therapy Gene therapy](https://vertassets.blob.core.windows.net/image/6890d72b/6890d72b-ddaa-490e-8b73-9a8a2b1ce582/375_250-gene_therapy.jpg)
Recombinant AAV is rapidly becoming the vector of choice for human gene therapy applications due to the ability to achieve prolonged gene expression in a variety of tissues without a significant immune response or toxicity. Our laboratory has discovered a number of novel AAV serotypes with enhanced gene expression and alternate tissue tropisms and has pioneered the study of these vectors for gene delivery.
Learn about Droplet Digital PCR (ddPCR™), how it works, and the technique's precision when determining AAV vector genome titers. ddPCR delivers a universal assay for all AAV vector types without some of the limitations of qPCR or the need to resort to separate methods.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.